EE236 Cost-Effectiveness of Ceftazidime/Avibactam Versus Meropenem in the Treatment of Complicated Intra-Abdominal Infections in China
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.484
https://www.valueinhealthjournal.com/article/S1098-3015(22)00685-4/fulltext
Title :
EE236 Cost-Effectiveness of Ceftazidime/Avibactam Versus Meropenem in the Treatment of Complicated Intra-Abdominal Infections in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00685-4&doi=10.1016/j.jval.2022.04.484
First page :
Section Title :
Open access? :
No
Section Order :
10429